Lilly to Invest $2.1 Billion in New Indiana Manufacturing Facilities

Eli Lilly and Company (Lilly) announced a $2.1 billion investment in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County. According to a company press release, the sites are intended to increase Lilly's manufacturing network for active ingredients and new therapeutic modalities, including genetic medicines.

“More than 146 years after our founding, Lilly remains committed to investing and innovating in Indiana," said David A. Ricks, Lilly's chair and CEO, in the company press release. "These new sites will add capacity in support of our growing pipeline of innovative medicines, while also creating more high-tech jobs for Hoosiers. We are pleased to be a founding investor at the LEAP Lebanon Innovation District."

This move follows Lilly’s 2019 expansion in Indiana, which saw $2.5 billion invested over five years. According to the release, this brought the current number of Lilly manufacturing employees to 3,700, while the current project is slated to add an additional 500 new Lilly roles and four indirect jobs for every Lilly position created.

"Lilly has been an anchor in Indiana's economy for generations, and this announcement means they will continue to be here for generations," said Indiana governor, Eric J. Holcomb, in the press release. "I am incredibly proud Lilly continues to make exciting investments in Indiana that will better the lives and opportunities of Hoosiers for decades to come. And in turn, the very research and pharmaceutical manufacturing spearheaded here in our state will improve lives worldwide."

Source: Eli Lilly and Company